Focus Partners Wealth’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Buy
+1,074
New +$372K ﹤0.01% 2207

Other funds holding KRYS

Focus Partners Wealth's KRYS Position: Q3 2026 in Review

Focus Partners Wealth opened a new position in Krystal Biotech (KRYS) in Q3 2026: 1,074 shares worth $357K. The stake represents ﹤0.01% of the portfolio and ranks #2207 among its holdings.

442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Focus Partners Wealth held 1,074 shares of Krystal Biotech worth $357K as of Q3 2026.
  • Krystal Biotech was a new Focus Partners Wealth position in Q3 2026.
  • Krystal Biotech made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #2207 holding.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.